Technical Analysis for NSTG - NanoString Technologies, Inc.

Grade Last Price % Change Price Change
grade F 21.85 -0.59% -0.13
NSTG closed down 0.59 percent on Friday, September 13, 2019, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NSTG trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -0.59%
Narrow Range Bar Range Contraction -0.59%

Older signals for NSTG ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
NanoString Technologies, Inc. engages in the development, manufacture, and sale instruments and consumables for use in life sciences research applications. The company provides nCounter Analysis System, an automated, multi-application, digital detection, and counting system that includes nCounter Prep Station, an automated liquid handling component for processing and preparing the samples for data collection; and nCounter Digital Analyzer, which collects data from samples through the images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. Its nCounter Analysis System supports research and the development of future clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, a data analysis program that offers nCounter Analysis System users the ability to quality check, normalize, and analyze their data. In addition, it provides gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits, and human karyotype panels; custom CodeSets; and master kits that are ancillary reagents, cartridges, tips, and reagent plates to setup and process samples in its instruments. Further, the company plans to develop and sell diagnostic kits for use in molecular diagnostic testing in clinical laboratories. It markets its systems and related consumables to researchers in academic, government, and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of disease in North America, Europe, the Middle East, and the Asia Pacific. The company was founded in 2003 and is headquartered in Seattle, Washington.
Medicine Chemistry Cancer Biology Disease Medical Tests Diagnostic Tests Gene Expression Molecular Diagnostics Laboratory Techniques Cancer Screening Clinical Applications Assay
Is NSTG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 34.78
52 Week Low 13.26
Average Volume 543,547
200-Day Moving Average 24.4422
50-Day Moving Average 27.2496
20-Day Moving Average 24.445
10-Day Moving Average 23.36
Average True Range 1.3211
ADX 27.98
+DI 14.201
-DI 32.6102
Chandelier Exit (Long, 3 ATRs ) 24.6167
Chandelier Exit (Short, 3 ATRs ) 25.4733
Upper Bollinger Band 28.2025
Lower Bollinger Band 20.6875
Percent B (%b) 0.15
BandWidth 30.742483
MACD Line -1.3756
MACD Signal Line -1.2085
MACD Histogram -0.1671
Fundamentals Value
Market Cap 550.7 Million
Num Shares 25.2 Million
EPS -2.12
Price-to-Earnings (P/E) Ratio -10.31
Price-to-Sales 2.46
Price-to-Book 4.80
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.62
Resistance 3 (R3) 22.61 22.35 22.49
Resistance 2 (R2) 22.35 22.16 22.35 22.44
Resistance 1 (R1) 22.10 22.03 21.97 22.11 22.40
Pivot Point 21.84 21.84 21.78 21.84 21.84
Support 1 (S1) 21.59 21.65 21.46 21.60 21.30
Support 2 (S2) 21.33 21.52 21.33 21.26
Support 3 (S3) 21.08 21.33 21.21
Support 4 (S4) 21.09